Total submissions: 3
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Centre for Mendelian Genomics, |
RCV001195804 | SCV001366224 | uncertain significance | Renpenning syndrome | 2020-03-30 | criteria provided, single submitter | clinical testing | This variant was classified as: Uncertain significance. The available evidence on this variant's pathogenicity is insufficient or conflicting. The following ACMG criteria were applied in classifying this variant: PM2,PP3. |
Ce |
RCV001311070 | SCV001501105 | uncertain significance | not provided | 2020-12-01 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV003235491 | SCV003933819 | uncertain significance | not specified | 2024-08-19 | criteria provided, single submitter | clinical testing | Variant summary: PQBP1 c.475C>T (p.Arg159Trp) results in a non-conservative amino acid change in the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The frequency data for this variant in gnomAD is considered unreliable, as metrics indicate poor data quality at this position. To our knowledge, no occurrence of c.475C>T in individuals affected with Renpenning syndrome and no experimental evidence demonstrating its impact on protein function have been reported. ClinVar contains an entry for this variant (Variation ID: 930267). Based on the evidence outlined above, the variant was classified as uncertain significance. |